B-CELL LEUKEMIA
Clinical trials for B-CELL LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new B-CELL LEUKEMIA trials appear
Sign up with your email to follow new studies for B-CELL LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New CAR-T therapy CLIC-2201 enters human trials for tough blood cancers
Disease control Recruiting nowThis early-phase trial tests a new treatment called CLIC-2201 for people with B-cell cancers (like certain leukemias and lymphomas) that have come back or not responded to standard therapy. CLIC-2201 is made from a patient's own immune cells, which are modified to better find and…
Matched conditions: B-CELL LEUKEMIA
Phase: PHASE1 • Sponsor: British Columbia Cancer Agency • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Next-Gen CAR-T takes on leukemia that escaped earlier treatments
Disease control Recruiting nowThis study tests a new type of CAR-T cell therapy for people with B-cell leukemia that does not have the CD19 marker or has come back after CD19-targeted treatment. The therapy uses a patient's own immune cells, modified to attack multiple targets on leukemia cells. The goal is t…
Matched conditions: B-CELL LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Apr 29, 2026 15:02 UTC